Oncology Molecular Diagnostics Market to Reach US$ 6.46 Billion by 2033, Driven by Precision Oncology, and Accelerating Biomarker-Based Therapies - According to Da…

DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics Market, which ...
PharmiWeb

Collaboration and co-marketing agreement with QIAGEN to advance CTC–based research with its pharmaceutical partners

Joint promotion of the Parsortix platform and QIAGEN’s molecular technologiesOpportunity for the development of a companion diagnostic assayGuildford, UK, –  18 November 2025 – CELLBXHEALTH plc (AIM: ...